Market by Product, Application, End-user, and Country | Forecast 2021-2028
Triton’s report has stated
that the pharmaceutical continuous manufacturing market in North America is
evaluated to advance at a CAGR of 10.07% during the predicted years 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The countries studied in this
market are:
• United States
• Canada
In North America, the studied
market is estimated to grow at a steady pace due to the well-developed
pharmaceutical industry and growth in the use of continuous manufacturing
systems. Additionally, the higher adoption of advanced technologies, innovative
continuous manufacturing systems, and trained professionals to operate complex
manufacturing equipment are another set of factors expected to motivate the
pharmaceutical continuous manufacturing market’s growth across North America.
In the United States,
pharmaceutical companies are considered to conduct half of global research and
development activities, with numerous companies holding the intellectual
property rights on several novel drugs. Further, multiple government
initiatives to support the utilization of continuous manufacturing technologies
are motivating the studied market’s progress to a large extent. For instance,
the US FDA is motivating pharma companies to adopt continuous manufacturing
methods, while providing faster approval processes. These factors significantly
drive the progression of the pharmaceutical continuous manufacturing market in
the United States.
Furthermore, significant
market players, such as Thermofisher and Munson Machinery, are also supporting
the studied market’s development. Moreover, due to the COVID-19 outbreak, the
country is likely to shift its manufacturing units from China to other parts of
Asia, which will reduce its dependency on the Chinese market for pharmaceutical
products. These factors are also likely to augment the pharmaceutical
continuous manufacturing market’s growth across the United States.
Munson Machinery Company is a
private and non-profit company providing processing machinery to its clients.
Moreover, it is regularly involved in the development of equipment performance
to compete with other manufacturers. Its product portfolio includes a rotary
continuous mixer that assists in reducing labor and operational cost
significantly when mixing dry mass of solids, with or without liquid
supplements. The company was founded in 1823, with its headquarter based in the
United States.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. NORTH
AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. PORTER’S
FIVE FORCES MODEL
2.1.1. THREAT
OF NEW ENTRANTS
2.1.2. THREAT
OF SUBSTITUTE PRODUCTS
2.1.3. BARGAINING
POWER OF BUYERS
2.1.4. BARGAINING
POWER OF SUPPLIERS
2.1.5. COMPETITIVE
RIVALRY
2.2. IMPACT
OF COVID-19 ON PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET
2.3. LEGAL,
POLICY, & REGULATORY FRAMEWORK
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
INSIGHTS
2.7. MARKET
DRIVERS
2.7.1. RISE
IN INITIATIVES TAKEN BY REGULATORY AUTHORITIES FOR THE ADOPTION OF CONTINUOUS
MANUFACTURING
2.7.2. SURGING
ACCEPTANCE OF PHARMACEUTICAL CONTINUOUS MANUFACTURING SYSTEMS
2.7.3. RISING
HEALTHCARE EXPENDITURE
2.8. MARKET
RESTRAINTS
2.8.1. RISING
CUSTOMER EXPECTATIONS FOR BETTER MEDICINES
2.9. MARKET
OPPORTUNITIES
2.9.1. SURGE
IN THE MANUFACTURING OF LARGE MOLECULES AND BIOLOGICS
3. NORTH
AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET OUTLOOK - BY PRODUCT
3.1. INTEGRATED
CONTINUOUS SYSTEM
3.2. SEMI-CONTINUOUS
SYSTEM
3.3. CONTROL
& SOFTWARE
4. NORTH
AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET OUTLOOK - BY APPLICATION
4.1. FINAL
DRUG PRODUCT MANUFACTURING
4.2. API
MANUFACTURING
5. NORTH
AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET OUTLOOK - BY END-USER
5.1. PHARMACEUTICAL
COMPANIES
5.2. CONTRACT
MANUFACTURING ORGANIZATIONS
5.3. OTHER
END-USERS
6. PHARMACEUTICAL
CONTINUOUS MANUFACTURING MARKET - NORTH AMERICA
6.1. COUNTRY
ANALYSIS
6.1.1. UNITED
STATES
6.1.2. CANADA
7. COMPANY
PROFILE
7.1. HOSOKAWA
MICRON CORPORATION
7.2. GEA
GROUP AG
7.3. LB
BOHLE MASCHINEN + VERFAHREN GMBH
7.4. THERMOFISHER
SCIENTIFIC INC
7.5. SIEMENS
HEALTHINEERS
7.6. ELI
LILLY & COMPANY
7.7. PFIZER
INC
7.8. GLATT
GMBH
7.9. SYNTEGON
(FORMERLY BOSCH PACKAGING TECHNOLOGY)
7.10. GEBRUDER
LODIGE MASCHINENBAU GMBH
7.11. KORSCH
AG
7.12. COPERION
GMBH
7.13. MUNSON
MACHINERY COMPANY
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.1.1. OBJECTIVES
OF STUDY
8.1.2. SCOPE
OF STUDY
8.2. SOURCES
OF DATA
8.2.1. PRIMARY
DATA SOURCES
8.2.2. SECONDARY
DATA SOURCES
8.3. RESEARCH
METHODOLOGY
8.3.1. EVALUATION
OF PROPOSED MARKET
8.3.2. IDENTIFICATION
OF DATA SOURCES
8.3.3. ASSESSMENT
OF MARKET DETERMINANTS
8.3.4. DATA
COLLECTION
8.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: NORTH AMERICA PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 2: NORTH AMERICA PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 3: NORTH AMERICA PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 4: NORTH AMERICA PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 5: NORTH AMERICA PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE 1: NORTH AMERICA PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET 2021-2028 (IN $ MILLION)
FIGURE 2: NORTH AMERICA PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY INTEGRATED CONTINUOUS SYSTEM, 2021-2028 (IN $ MILLION)
FIGURE 3: NORTH AMERICA PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY SEMI-CONTINUOUS SYSTEM, 2021-2028 (IN $ MILLION)
FIGURE 4: NORTH AMERICA PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY CONTROL & SOFTWARE, 2021-2028 (IN $ MILLION)
FIGURE 5: NORTH AMERICA PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY FINAL DRUG PRODUCT MANUFACTURING, 2021-2028 (IN $
MILLION)
FIGURE 6: NORTH AMERICA PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY API MANUFACTURING, 2021-2028 (IN $ MILLION)
FIGURE 7: NORTH AMERICA PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY PHARMACEUTICAL COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 8: NORTH AMERICA PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY CONTRACT MANUFACTURING ORGANIZATIONS, 2021-2028 (IN $
MILLION)
FIGURE 9: NORTH AMERICA PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)
FIGURE 10: UNITED STATES PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET 2021-2028 (IN $ MILLION)
FIGURE 11: CANADA PHARMACEUTICAL CONTINUOUS MANUFACTURING
MARKET 2021-2028 (IN $ MILLION)